BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18242184)

  • 1. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
    Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
    FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossregulation of beta-catenin/Tcf pathway by NF-kappaB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells.
    Hyun Hwa Cho ; Hye Joon Joo ; Ji Sun Song ; Yong Chan Bae ; Jin Sup Jung
    Biochim Biophys Acta; 2008 Mar; 1783(3):419-28. PubMed ID: 17950943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
    Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
    FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB.
    Gwak J; Park S; Cho M; Song T; Cha SH; Kim DE; Jeon YJ; Shin JG; Oh S
    Int J Mol Med; 2006 Jun; 17(6):1005-10. PubMed ID: 16685408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
    Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
    Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-induced down-regulation of beta-catenin in colon cancer cells by a proteasome-independent specific pathway.
    Prévotat L; Filomenko R; Solary E; Jeannin JF; Bettaieb A
    Gastroenterology; 2006 Oct; 131(4):1142-52. PubMed ID: 17030184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
    Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor.
    Kim JM; Song JS; Cho HH; Shin KK; Bae YC; Lee BJ; Jung JS
    Mol Cell Biochem; 2011 Jan; 346(1-2):125-36. PubMed ID: 20890637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy approach in prostate cancer cells using an active Wnt signal.
    Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
    Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the glutathione peroxidase 2 (GPx2) promoter by beta-catenin.
    Kipp A; Banning A; Brigelius-Flohé R
    Biol Chem; 2007 Oct; 388(10):1027-33. PubMed ID: 17937616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Watanabe J; Kawaguchi M; Okayasu I
    J Pathol; 2008 Dec; 216(4):521-32. PubMed ID: 18798221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF.
    Torisu Y; Watanabe A; Nonaka A; Midorikawa Y; Makuuchi M; Shimamura T; Sugimura H; Niida A; Akiyama T; Iwanari H; Kodama T; Zeniya M; Aburatani H
    Cancer Sci; 2008 Jun; 99(6):1139-46. PubMed ID: 18429952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
    Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
    Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB.
    Kashima L; Toyota M; Mita H; Suzuki H; Idogawa M; Ogi K; Sasaki Y; Tokino T
    Oncogene; 2009 Jul; 28(29):2643-53. PubMed ID: 19448676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.